E.E. Geduld’s Halozyme HALO Stock Holding History

E.E. Geduld’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-12,500	Closed	-$168K	–	205
2015 Q3	$168K	Sell	12,500 -22,550	-64%	-$453K	0.16%	109
2015 Q2	$791K	Hold	35,050	–	–	0.49%	34
2015 Q1	$501K	Buy	35,050 +5,000	+17%	+$72.1K	0.33%	69
2014 Q4	$290K	Sell	30,050 -15,000	-33%	-$133K	0.16%	111
2014 Q3	$410K	Sell	45,050 -5,000	-10%	-$47.6K	0.29%	82
2014 Q2	$494K	Sell	50,050 -23,000	-31%	-$195K	0.31%	75
2014 Q1	$928K	Buy	73,050 +8,050	+12%	+$119K	0.5%	38
2013 Q4	$974K	Hold	65,000	–	–	0.47%	36
2013 Q3	$718K	Sell	65,000 -10,000	-13%	-$83.3K	0.44%	50
2013 Q2	$596K	Buy	+75,000	New	+$478K	0.42%	59

Other funds holding HALO

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

E.E. Geduld's HALO Position: Q4 2015 in Review

E.E. Geduld sold out of Halozyme (HALO) in Q4 2015, closing a stake of 12,500 shares — an estimated $168K sold.

E.E. Geduld first reported a position in HALO in Q2 2013 and held it in 10 quarters. The position peaked at $974K in Q4 2013. 166 funds tracked by Wall St. Rank hold HALO as of Q4 2015.

E.E. Geduld reported no remaining Halozyme position as of Q4 2015 after selling out during the quarter.
E.E. Geduld sold 12,500 Halozyme shares in Q4 2015, an estimated $168K.
E.E. Geduld first reported a position in Halozyme in Q2 2013 and held it in 10 quarters.
E.E. Geduld's Halozyme position peaked at $974K in Q4 2013.
166 funds tracked by Wall St. Rank held Halozyme as of Q4 2015.

Based on E.E. Geduld's 13F filing for Q4 2015, filed 2 Feb 2016.